Lipoprotein (A) levels in type 2 diabetic patients with diabetic retinopathy

Medical Journal of Malaysia

Volumn 59, Issue 3, 2004, Pages 406-410

  Ergun, U Guney Ozer ^a   Oztuzun S ^b   Seydaoglu, G ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetic retinopathy; Lipoprotein (a); Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; CREATININE; LIPOPROTEIN A; NITROGEN;

ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; TURKEY (REPUBLIC);

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITROGEN; REGRESSION ANALYSIS; TURKEY;

EID: 18444379074     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. J Am Med 1979; 64: 221-30.
2. American Diabetes Association. Implication of the United Kingdom Prospective Diabetes Study. Diabetes Care 2003; 26(1): 28-32.
3. American Diabetes Association. Diabetic retinopathy. Diabetes Care 2002; 25: 90-93.
4. De Fine Olivarius N, Nielsen NV, Andreanas AH. Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 2001; 239(9): 664-72.
5. Uttermann G. The mysteries of lipoprotein(a). Science 1989; 246: 904-10.
6. Scott J. Thrombogenesis linked to atherogenesis at last? Nature 1989; 341: 22-23.
7. Maher VMG, Brown BG. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 1995; 6: 229-35.
8. Hiraga T, Kobayashi T, Okubo M, et al. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 1995; 18: 241-44.
9. Gazzaruso C, Garzanti A, Buscaglia P, Dannunzio G, et al. Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetol 1998; 35: 13-8.
10. Tarkun I, Cetinarslan B, Canturk Z. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications. Nutr Metab Cardiovasc Dis 2002; 12(3): 127-31.
11. Guerci B, Meyer L, Sommer S, et al. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients. Diabetes Metab 1999; 25: 412-8.
12. Suzuki T, Oba K, Igari Y, et al. Relation of apolipoprotein (a) phenotypes to diabetic retinopathy in elderly type 2 diabetes. J Nippon Med Sch 2002; 69(1): 31-8.
13. Kim CH, Park HJ, Park JY, et al. High serum lipoprotein (a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Diabetes Care 1997; 21: 2149-151.
14. Deepa R, Mohan A, Rema M, et al. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications. J Assoc Physicians India 2002; 50: 657-61.
15. Westerhuis LW, Venekamp WJ. Serum Lipoprotein-a levels and glyco-metabolic control in insulin and non-insulin dependent diabetes mellitus. Clin Biochem 1996; 29: 255-9.
16. Maioli M, Tonolo G, Pacifico A, et al. Raised serum apolipoprotein (a) in active diabetic retinopathy. Diabetologia 1993; 36: 88-90.
17. Liu DP, Molyneaux L, Chua E, et al. Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract 2002; 56: 125-31.
18. Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complications 2001; 15: 287-94.
19. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156-63.